{"id":53349,"date":"2026-02-23T12:38:31","date_gmt":"2026-02-23T12:38:31","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/small-molecules-contract-development-and-manufacturing-organization-market-mordor\/"},"modified":"2026-04-03T10:42:16","modified_gmt":"2026-04-03T01:42:16","slug":"small-molecules-contract-development-and-manufacturing-organization-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/small-molecules-contract-development-and-manufacturing-organization-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc800\ubd84\uc790 \ud654\ud569\ubb3c \uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0\uae30\uad00 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/small-molecules-contract-development-and-manufacturing-organization-market_1695886712924_1141413.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/small-molecules-contract-development-and-manufacturing-organization-market-size-image-1771506698266.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc18c\ubd84\uc790 R&amp;D \ud30c\uc774\ud504\ub77c\uc778 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc81c\uc57d \ube44\uc6a9 \uc808\uac10\uc73c\ub85c CDMO \ucc44\ud0dd \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.3 \uace0\uc5ed\uac00 API(HPAPI) \uc218\uc694 \uae09\uc99d<\/li>\n<li class=\"toc-level-3\">4.2.4 \ud2b9\ud5c8 \ub9cc\ub8cc \ud6c4 \uc81c\ub124\ub9ad \ubb3c\ub7c9 \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.5 \ub9c8\uc774\ud06c\ub85c \ubc30\uce58 API\ub97c \uc704\ud55c AI \uae30\ubc18 \uacf5\uc815 \uac15\ud654<\/li>\n<li class=\"toc-level-3\">4.2.6 ESG \uc8fc\ub3c4 \ud575\uc2ec API \uc0dd\uc0b0 \ub2a5\ub825 \uad6d\ub0b4 \ubcf5\uadc0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc0dd\uc0b0 \ub2a5\ub825 \ubd80\uc871 \ubc0f \uae34 CDMO \ub9ac\ub4dc \ud0c0\uc784<\/li>\n<li class=\"toc-level-3\">4.3.2 \uaddc\uc81c \ubbf8\uc900\uc218 \/ FDA \uacbd\uace0 \uc11c\ud55c<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc911\uad6d\uc0b0 \uace0\uae09 \uc911\uac04\uccb4\uc5d0 \ub300\ud55c \uacfc\ub3c4\ud55c \uc758\uc874<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc5d0\ub108\uc9c0 \uac00\uaca9 \ubcc0\ub3d9\uc131\uc73c\ub85c \uc778\ud55c \ub9c8\uc9c4 \uc555\ubc15<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.6.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc11c\ube44\uc2a4 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 API \uac1c\ubc1c<\/li>\n<li class=\"toc-level-3\">5.1.2 API \uc81c\uc870<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc644\uc81c \uc758\uc57d\ud488 \uac1c\ubc1c<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc644\uc81c \uc758\uc57d\ud488 \uc81c\uc870<\/li>\n<li class=\"toc-level-3\">5.1.5 \uc81c\ud615 &amp; \ubd84\uc11d \uc11c\ube44\uc2a4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc6b4\uc601 \uaddc\ubaa8\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc804\uc784\uc0c1<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc784\uc0c1 \u2013 1\uc0c1<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc784\uc0c1 \u2013 2\uc0c1<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc784\uc0c1 \u2013 3\uc0c1<\/li>\n<li class=\"toc-level-3\">5.2.5 \uc0c1\uc5c5\ud654<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uce58\ub8cc \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc2ec\ud608\uad00<\/li>\n<li class=\"toc-level-3\">5.3.3 \uac10\uc5fc\ubcd1<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ucd94\uc2e0\uacbd\uacc4<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub300\uc0ac \uc7a5\uc560<\/li>\n<li class=\"toc-level-3\">5.3.6 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uace0\uac1d \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ub300\ud615 \uc81c\uc57d\uc0ac<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc911\uc18c\ud615 \uc81c\uc57d\uc0ac<\/li>\n<li class=\"toc-level-3\">5.4.3 \ubc14\uc774\uc624\ud14d \uae30\uc5c5<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \ud68c\uc0ac<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Ajinomoto Bio-Pharma Services<\/li>\n<li class=\"toc-level-3\">6.3.2 Alcami Corporation<\/li>\n<li class=\"toc-level-3\">6.3.3 Cambrex Corporation<\/li>\n<li class=\"toc-level-3\">6.3.4 Catalent Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 CordenPharma International<\/li>\n<li class=\"toc-level-3\">6.3.6 Delpharm<\/li>\n<li class=\"toc-level-3\">6.3.7 Dottikon ES Holdings AG<\/li>\n<li class=\"toc-level-3\">6.3.8 Eurofins CDMO<\/li>\n<li class=\"toc-level-3\">6.3.9 Evonik Industries AG<\/li>\n<li class=\"toc-level-3\">6.3.10 Fareva<\/li>\n<li class=\"toc-level-3\">6.3.11 Jubilant Pharmova Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.12 Lonza Group AG<\/li>\n<li class=\"toc-level-3\">6.3.13 Labcorp Drug Development<\/li>\n<li class=\"toc-level-3\">6.3.14 Olon S.p.A<\/li>\n<li class=\"toc-level-3\">6.3.15 Piramal Pharma Solutions<\/li>\n<li class=\"toc-level-3\">6.3.16 Recipharm AB<\/li>\n<li class=\"toc-level-3\">6.3.17 Siegfried Holding AG<\/li>\n<li class=\"toc-level-3\">6.3.18 Sterling Pharma Solutions<\/li>\n<li class=\"toc-level-3\">6.3.19 Thermo Fisher Scientific, Inc<\/li>\n<li class=\"toc-level-3\">6.3.20 WuXi STA<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc18c\ubd84\uc790 \uc758\uc57d\ud488 \uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0(CDMO) \uc2dc\uc7a5 \ubcf4\uace0\uc11c 2031: \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 2020\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc18c\ubd84\uc790 \uc758\uc57d\ud488 \uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0(CDMO) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud558\uba70, \uc2dc\uc7a5 \uaddc\ubaa8, \uc131\uc7a5 \ub3d9\ud5a5, \uc8fc\uc694 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778, \uc11c\ube44\uc2a4 \uc720\ud615\ubcc4, \uc6b4\uc601 \uaddc\ubaa8\ubcc4, \uce58\ub8cc \uc601\uc5ed\ubcc4, \uace0\uac1d \uc720\ud615\ubcc4, \uc9c0\uc5ed\ubcc4 \uc138\ubd84\ud654 \ubd84\uc11d \ubc0f \uacbd\uc7c1 \ud658\uacbd\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8e8\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd<\/p>\n<p>\uc18c\ubd84\uc790 \uc758\uc57d\ud488 CDMO \uc2dc\uc7a5\uc740 2025\ub144 1,945\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 2,071\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc99d\uac00\ud558\uace0, 2031\ub144\uc5d0\ub294 2,903\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.98%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc73c\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774\ub7ec\ud55c \uc131\uc7a5\uc740 2027\ub144\uae4c\uc9c0 1,500\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \ube0c\ub79c\ub4dc \uc758\uc57d\ud488 \ud2b9\ud5c8 \ub9cc\ub8cc\uac00 \uc608\uc0c1\ub428\uc5d0 \ub530\ub77c, \uc624\ub9ac\uc9c0\ub110 \uc81c\uc57d\uc0ac\ub4e4\uc774 \uc790\uc0b0 \uacbd\ub7c9\ud654 \uc0dd\uc0b0 \uc804\ub7b5\uc744 \ucd94\uad6c\ud558\uba70 \uc678\ubd80 \uc81c\uc870 \ud30c\ud2b8\ub108\uc5d0 \ub300\ud55c \uc758\uc874\ub3c4\ub97c \ub192\uc774\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ub610\ud55c, Novo Holdings\uc758 Catalent \uc778\uc218\uc640 \uac19\uc740 \ud1b5\ud569 \uc6c0\uc9c1\uc784\uc774 \ud65c\ubc1c\ud558\uba70, \uc784\uc0c1 \ub2e8\uacc4 \uc2ac\ub86f\uc774 18~24\uac1c\uc6d4 \uc804\uc5d0 \uc608\uc57d\ub418\ub294 \ub4f1 \uc5ec\uc804\ud788 \uc0dd\uc0b0 \ub2a5\ub825 \ubcd1\ubaa9 \ud604\uc0c1\uc774 \uc874\uc7ac\ud569\ub2c8\ub2e4. 2024\ub144 120\uc5b5 \ub2ec\ub7ec\uc758 \ubca4\ucc98 \uce90\ud53c\ud0c8 \ud22c\uc790\uac00 \uc774\ub8e8\uc5b4\uc9c0\uba70 \ubc14\uc774\uc624\ud14d \uc790\uae08 \uc870\ub2ec\uc774 \uac15\ub825\ud558\uac8c \ubc18\ub4f1\ud588\uace0, \uc774\ub294 \uac1c\ubc1c \uae30\uac04\uc744 \ucd5c\ub300 40% \ub2e8\ucd95\ud560 \uc218 \uc788\ub294 \uc720\uc5f0\ud55c \uac1c\ubc1c \uc5ed\ub7c9\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \ubd80\ud65c\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \ub3d9\uc2dc\uc5d0 \uc9c0\uc815\ud559\uc801 \uc704\ud5d8\uacfc 2024\ub144 \ubbf8\uad6d BIOSECURE Act\ub294 \ub2e8\uc77c \uad6d\uac00 \uc758\uc874\ub3c4\uc5d0\uc11c \ubc97\uc5b4\ub098 \ubd81\ubbf8, \uc778\ub3c4, \uc720\ub7fd\uc744 \uc544\uc6b0\ub974\ub294 \ub2e4\uc911 \ub178\ub4dc \ub124\ud2b8\uc6cc\ud06c\ub85c \uacf5\uae09\ub9dd\uc744 \uc7ac\ud3b8\ud558\ub294 \ucd09\ub9e4\uc81c\uac00 \ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uc11c\ube44\uc2a4 \uc720\ud615\ubcc4: 2025\ub144 \uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 41.02%\ub97c API(\uc6d0\ub8cc\uc758\uc57d\ud488) \uc81c\uc870\uac00 \ucc28\uc9c0\ud588\uc73c\uba70, \uc81c\ud615 \ubc0f \ubd84\uc11d \uc11c\ube44\uc2a4\ub294 2031\ub144\uae4c\uc9c0 7.29%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc6b4\uc601 \uaddc\ubaa8\ubcc4: 2025\ub144 \uc0c1\uc5c5 \uc0dd\uc0b0 \uaddc\ubaa8\uac00 34.27%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ucef8\uc73c\uba70, \uc784\uc0c1 3\uc0c1 \uc0dd\uc0b0 \ub2a5\ub825\uc740 2031\ub144\uae4c\uc9c0 9.93%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc601\uc5ed\ubcc4: 2025\ub144 \ub9e4\ucd9c\uc758 55.12%\ub97c \uc885\uc591\ud559 \ubd84\uc57c\uac00 \ucc28\uc9c0\ud588\uc73c\uba70, \uc911\ucd94\uc2e0\uacbd\uacc4(CNS) \ud30c\uc774\ud504\ub77c\uc778\uc740 2031\ub144\uae4c\uc9c0 8.43%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<br \/>\n*   \uace0\uac1d \uc720\ud615\ubcc4: 2025\ub144 \uc911\uc18c\ud615 \uc81c\uc57d\uc0ac\uac00 37.08%\uc758 \ub9e4\ucd9c\uc744 \uae30\ub85d\ud588\uc73c\uba70, \ubc14\uc774\uc624\ud14d \uae30\uc5c5\uc774 2031\ub144\uae4c\uc9c0 8.68%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uace0\uac1d\uad70\uc774 \ub420 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ubd81\ubbf8\uac00 \uc2dc\uc7a5 \uac00\uce58\uc758 39.63%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 11.63%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825 (\uc131\uc7a5 \ub3d9\uc778)<\/p>\n<p>*   \ube45 \ud30c\ub9c8\uc758 API \ubc0f \uc644\uc81c \uc758\uc57d\ud488(FDF) \uc81c\uc870 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00: \uc81c\uc57d\uc0ac\ub4e4\uc740 API \uac1c\ubc1c\uc758 73%, \uc644\uc81c \uc758\uc57d\ud488 \uc81c\uc870\uc758 65%\ub97c \uc544\uc6c3\uc18c\uc2f1\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 2023\ub144 \ub300\ube44 \uc99d\uac00\ud55c \uc218\uce58\uc785\ub2c8\ub2e4. \ud2b9\ud788 \uac00\uc0c1 \uc81c\uc57d\uc0ac(Virtual Pharma)\ub294 \uc784\uc0c1 2\/3\uc0c1 \uc790\uc0b0\uc758 40%\ub97c \ubcf4\uc720\ud558\uace0 \uc788\uc5b4 CDMO \uac00\uc6a9\uc131\uc5d0 \uc804\uc801\uc73c\ub85c \uc758\uc874\ud569\ub2c8\ub2e4. \uc784\uc0c1 3\uc0c1 \uc0dd\uc0b0 \ub2a5\ub825 \ud65c\uc6a9\ub960\uc740 \uc774\ubbf8 85%\ub97c \ucd08\uacfc\ud558\uc5ec, \uc2a4\ud3f0\uc11c\ub4e4\uc740 \ub2e4\ub144\uac04\uc758 \ub2e4\uc911 \uc11c\ube44\uc2a4 \uacc4\uc57d\uc744 \uc870\uae30\uc5d0 \uc608\uc57d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud569\uc131, \uc81c\ud615, \ud14c\uc2a4\ud2b8\ub97c \ud55c \uacf3\uc5d0\uc11c \ucc98\ub9ac\ud558\ub294 \ud1b5\ud569 \ucea0\ud37c\uc2a4\uac00 \ubd84\uc11d \uc804\uc1a1 \uc9c0\uc5f0\uc744 \uc5c6\uc560\uba74\uc11c \uc120\ud638\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc57d \ube44\uc6a9 \uc808\uac10 \uac00\uc18d\ud654 \ubc0f CDMO \ucc44\ud0dd: \uc81c\uc870 \ube44\uc6a9\uc740 \uc81c\uc57d \ub9e4\ucd9c\uc758 \ud3c9\uade0 25%\ub97c \ucc28\uc9c0\ud558\uc9c0\ub9cc, \uc218\uc728 \ucd5c\uc801\ud654 \ubc0f \uacf5\uae09\ub9dd \ud569\ub9ac\ud654\ub97c \ud1b5\ud574 \uc81c\uc870\uc6d0\uac00(COGS)\ub97c \ucd5c\ub300 25% \uc808\uac10\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144\ubd80\ud130 2026\ub144 \ucd08\uae4c\uc9c0 \uc624\ub9ac\uc9c0\ub110 \uc81c\uc57d\uc0ac\ub4e4\uc740 18\uac1c \uacf5\uc7a5\uc744 \ub9e4\uac01\ud558\uace0 \ubc14\uc774\uc624 \uc758\uc57d\ud488\uc5d0 \uc790\ubcf8\uc744 \uc7ac\ubc30\uce58\ud558\uba70 \uc18c\ubd84\uc790 \uc758\uc57d\ud488 \uc0dd\uc0b0\uc744 \uc678\ubd80 \ud30c\ud2b8\ub108\uc5d0\uac8c \uc704\ud0c1\ud588\uc2b5\ub2c8\ub2e4. Eliquis \ubc0f Keytruda\uc640 \uac19\uc740 \uc8fc\uc694 \uc758\uc57d\ud488\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc\uac00 \uc784\ubc15\ud558\uba74\uc11c \ubb3c\ub7c9 \uc57d\uc815\uc5d0 \ub530\ub978 \uacc4\uce35\ubcc4 \uac00\uaca9 \uacc4\uc57d\uc774 \ucd09\uc9c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud1b5\ud569 CDMO-CRO \ubaa8\ub378\uc740 \uac1c\ubc1c \uc2dc\uac04\uc744 30-40% \ub2e8\ucd95\ud558\uc5ec \ubc14\uc774\uc624\ud14d\uc758 \uc790\uc0b0 \uc21c\ud604\uc7ac\uac00\uce58(NPV)\ub97c \ud5a5\uc0c1\uc2dc\ud0b5\ub2c8\ub2e4. \uc5d0\ub108\uc9c0 \uc9d1\uc57d\uc801\uc778 \ud569\uc131\uc740 \uc11c\uc720\ub7fd\uc758 0.13\ub2ec\ub7ec\/kWh\uc5d0 \ube44\ud574 0.07\ub2ec\ub7ec\/kWh\uc758 \uc0b0\uc5c5\uc6a9 \uc804\ub825 \ube44\uc6a9\uc744 \uac00\uc9c4 \uc778\ub3c4\ub85c \uc774\ub3d9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uace0\uc5ed\uac00 \uc6d0\ub8cc\uc758\uc57d\ud488(HPAPI) \uc218\uc694 \uae09\uc99d: \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC) \ubc0f \ud45c\uc801 \ud56d\uc554\uc81c\ub294 OEL(Occupational Exposure Limit) 5\ub4f1\uae09 \uc791\uc5c5\uc774 \uac00\ub2a5\ud55c \uaca9\ub9ac \uc2dc\uc124\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \uacac\uc778\ud569\ub2c8\ub2e4. Lonza, Siegfried, Carbogen Amcis\ub294 2024-2025\ub144 \ub3d9\uc548 \uc0c8\ub85c\uc6b4 HPAPI \ub77c\uc778\uc5d0 3\uc5b5 \ub2ec\ub7ec \uc774\uc0c1\uc744 \ud22c\uc790\ud588\uc2b5\ub2c8\ub2e4. FDA\ub294 2024\ub144 12\uac1c HPAPI \uc2dc\uc124\uc5d0 \uad50\ucc28 \uc624\uc5fc \uc704\ud5d8\uc73c\ub85c Form 483 \uad00\ucc30\uc744 \ubc1c\ud589\ud558\uba70 \uaddc\uc81c \uac10\ub3c5\uc744 \uac15\ud654\ud588\uc2b5\ub2c8\ub2e4. \uc5f0\uc18d \ud750\ub984 \ubc18\uc751\uae30 \ubc0f \ubc00\ud3d0\ud615 \uace0\uccb4 \ucc98\ub9ac \uc2dc\uc2a4\ud15c\uc740 \uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5\uc5d0\uc11c \uc885\uc591\ud559 \ud504\ub85c\uadf8\ub7a8\uc744 \uc218\uc8fc\ud558\ub294 \ub370 \ud544\uc218\uc801\uc778 \uc694\uc18c\uc785\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ub9c8\uc774\ud06c\ub85c \ubc30\uce58 API \uacf5\uc815 \uac15\ud654: \uba38\uc2e0\ub7ec\ub2dd \uc54c\uace0\ub9ac\uc998\uc740 \ubc18\uc751 \ucd5c\uc801\ud654 \uc2dc\uac04\uc744 60-70% \ub2e8\ucd95\ud558\uc5ec \uac1c\ubc1c \uc8fc\uae30\ub97c \uc57d 12\uac1c\uc6d4\ub85c \uc904\uc785\ub2c8\ub2e4. \ud750\ub984 \ud654\ud559(Flow chemistry) \uc124\ube44\ub294 \ubc30\uce58 \ud06c\uae30\ub97c 80% \uc904\uc774\uba74\uc11c\ub3c4 \uc218\uc728 \uc77c\uad00\uc131\uc744 \ub192\uc774\uba70, \uc2e4\uc2dc\uac04 PAT(Process Analytical Technology)\ub294 \uc989\uac01\uc801\uc778 \ucd9c\uc2dc\ub97c \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. FDA\uc758 \uc2e0\uae30\uc220 \ud504\ub85c\uadf8\ub7a8\uc740 2024-2025\ub144\uc5d0 8\uac1c\uc758 \uc5f0\uc18d \uc81c\uc870 \uc9c0\uc815\uc744 \uc2b9\uc778\ud558\uc5ec \ub370\uc774\ud130 \uae30\ubc18 \uc81c\uc5b4 \uc804\ub7b5\uc5d0 \ub300\ud55c \uaddc\uc81c \ub2f9\uad6d\uc758 \uc218\uc6a9\ub3c4\ub97c \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>*   \uc0dd\uc0b0 \ub2a5\ub825 \ubd80\uc871 \ubc0f CDMO \uae34 \ub9ac\ub4dc \ud0c0\uc784: 2025\ub144 \ub9d0 \uc784\uc0c1 \uc81c\uc870 \uc2ac\ub86f\uc740 85%\uc758 \ud65c\uc6a9\ub960\ub85c \uc6b4\uc601\ub418\uc5c8\uc73c\uba70, \ub9ac\ub4dc \ud0c0\uc784\uc740 \ucd5c\ub300 24\uac1c\uc6d4\uc5d0 \ub2ec\ud588\uc2b5\ub2c8\ub2e4. COVID-19 \ud32c\ub370\ubbf9 \uc2dc\uae30 \ubc31\uc2e0 \uc0dd\uc0b0\uc73c\ub85c\uc758 \uc7ac\ubc30\uce58\ub294 \uc18c\ubd84\uc790 \uc0dd\uc0b0 \uc2dc\uc124\uc758 \uad6c\uc870\uc801 \ubd80\uc871\uc744 \uc57c\uae30\ud588\uc73c\uba70, \uc774\ub294 2027\ub144\uae4c\uc9c0 \uc644\uc804\ud788 \ud574\uc18c\ub418\uc9c0 \uc54a\uc744 \uac83\uc785\ub2c8\ub2e4. \uc774\uc911 \uc18c\uc2f1\uc740 \uc77c\uc815 \uc704\ud5d8\uc744 \uc644\ud654\ud558\uc9c0\ub9cc, \uae30\uc220 \uc774\uc804 \ube44\uc6a9\uc744 \ucd5c\ub300 50% \uc99d\uac00\uc2dc\ud0a4\uace0 \ube44\uad50 \uac00\ub2a5\uc131 \uc11c\ub958 \uc791\uc5c5\uc744 \ubcf5\uc7a1\ud558\uac8c \ub9cc\ub4ed\ub2c8\ub2e4.<br \/>\n*   \uaddc\uc81c \ubbf8\uc900\uc218 \ubc0f FDA \uacbd\uace0 \uc11c\ud55c: 2024\ub144 Gland Pharma, Fresenius Kabi, Intas Pharma\uc5d0 \ub300\ud55c FDA \uacbd\uace0 \uc11c\ud55c\uc740 15-20\uac1c \uc644\uc81c \uc758\uc57d\ud488 \uc0dd\uc0b0 \ub77c\uc778\uc5d0 \ucc28\uc9c8\uc744 \ube5a\uc5c8\uace0, \uc2a4\ud3f0\uc11c\uc758 \uac10\uc0ac \ube44\uc6a9\uc744 \uc57d 25% \uc99d\uac00\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. EMA\ub294 2025\ub144 \uc544\uc2dc\uc544 8\uac1c \uc2dc\uc124\uc5d0 \ub300\ud574 GMP(Good Manufacturing Practice) \uc704\ubc18\uc744 \uc9c0\uc801\ud558\uba70 \uc218\uc785 \uc2ec\uc0ac\ub97c \uac15\ud654\ud560 \uac83\uc744 \uc608\uace0\ud588\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \uc900\uc218 \ube44\uc6a9\uc740 CDMO \uc6b4\uc601 \uc608\uc0b0\uc758 \ucd5c\ub300 12%\ub97c \ucc28\uc9c0\ud558\uc5ec \uae30\uc220 \uc5c5\uadf8\ub808\uc774\ub4dc\ub97c \uc704\ud55c \uc7ac\ub7c9\uc801 \uc790\ubcf8 \uc9c0\ucd9c\uc744 \uc81c\ud55c\ud558\uace0 \ub9c8\uc9c4 \ud655\ub300\ub97c \uc800\ud574\ud569\ub2c8\ub2e4.<\/p>\n<p>5. \uc138\ubd84\ud654 \ubd84\uc11d<\/p>\n<p>*   \uc11c\ube44\uc2a4 \uc720\ud615\ubcc4: \ud1b5\ud569 \uc81c\ud615 \uc218\uc694 \uc99d\uac00<br \/>\n    *   \uc81c\ud615 \ubc0f \ubd84\uc11d \uc11c\ube44\uc2a4\ub294 2031\ub144\uae4c\uc9c0 7.29%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. API \uc81c\uc870\ub294 2025\ub144 \uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5\uc758 41.02%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\uc804\ud788 \ud575\uc2ec\uc801\uc778 \uc5ed\ud560\uc744 \ud558\uc9c0\ub9cc, \uc800\ube44\uc6a9 \uc544\uc2dc\uc544 \uacf5\uc7a5\uc758 \uc0c1\ud488\ud654 \uc555\ub825\uc5d0 \uc9c1\uba74\ud574 \uc788\uc2b5\ub2c8\ub2e4. \uc774\uc81c\ub294 \ud569\uc131, \uc81c\ud615, QC\ub97c \ud55c \uacf3\uc5d0\uc11c \ucc98\ub9ac\ud558\uc5ec \uac1c\ubc1c \uc77c\uc815\uc744 30-40% \ub2e8\ucd95\ud558\ub294 \uc6d0\ud65c\ud55c \ud578\ub4dc\uc624\ud504\uc5d0 \ub300\ud55c \ud504\ub9ac\ubbf8\uc5c4\uc774 \ubd99\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2a4\ud504\ub808\uc774 \uac74\uc870 \ubd84\uc0b0, \uace0\uc628 \uc6a9\uc735 \uc555\ucd9c \ub610\ub294 \uc9c0\uc9c8 \uae30\ubc18 \uc2dc\uc2a4\ud15c\uc744 \uc804\ubb38\uc73c\ub85c \ud558\ub294 CDMO\ub294 \ub09c\uc6a9\uc131 \ud654\ud569\ubb3c\uc758 \uc6a9\ud574\ub3c4\ub97c \uac1c\uc120\ud558\uc5ec 25-40%\uc758 \uac00\uaca9 \ud504\ub9ac\ubbf8\uc5c4\uc744 \ud655\ubcf4\ud569\ub2c8\ub2e4. \uc644\uc81c \uc758\uc57d\ud488 \uc81c\uc870\ub294 \uc218\uba85 \uc8fc\uae30 \uad00\ub9ac \uc7ac\uc81c\ud615\uc5d0 \ud798\uc785\uc5b4 6.8%\uc758 CAGR\ub85c \uafb8\uc900\ud788 \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc6b4\uc601 \uaddc\ubaa8\ubcc4: 3\uc0c1 \uc0dd\uc0b0 \ub2a5\ub825 \ubd80\uc871<br \/>\n    *   \uc0c1\uc5c5 \uc0dd\uc0b0\uc740 2025\ub144 \ub9e4\ucd9c\uc758 34.27%\ub97c \ucc28\uc9c0\ud558\uba70 \uc120\ub450\ub97c \ub2ec\ub838\uc9c0\ub9cc, \uc784\uc0c1 3\uc0c1 \ud65c\ub3d9\uc740 9.93%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc2e0\uaddc \uc790\ubcf8 \uc9c0\ucd9c\uc744 \ud53c\ud558\ub824\ub294 \uc131\uc219\ud55c \ubc14\uc774\uc624\ud14d \uae30\uc5c5\ub4e4\uc758 \uacbd\ud5a5\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. 2025\ub144 \uc784\uc0c1 3\uc0c1 \ud65c\uc6a9\ub960\uc740 85%\ub97c \ucd08\uacfc\ud588\uc73c\uba70, \uc2a4\ud3f0\uc11c\ub4e4\uc740 2\ub144 \uc804\uc5d0 \uc2ac\ub86f\uc744 \uc608\uc57d\ud558\uc5ec \ubcf4\uc99d\uae08 \uc694\uad6c \uc0ac\ud56d\uc744 \ub192\uc774\uace0 \uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5\uc758 \ud30c\uc774\ud504\ub77c\uc778\uc744 \ub354\uc6b1 \uc555\ubc15\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc601\uc5ed\ubcc4: \uc885\uc591\ud559\uc758 \uc9c0\uc18d\uc801\uc778 \uac15\uc138, CNS\uc758 \ubd80\uc0c1<br \/>\n    *   \uc885\uc591\ud559\uc740 2025\ub144 \ub9e4\ucd9c\uc758 55.12%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 180\uac1c\uc758 ADC \ud504\ub85c\uadf8\ub7a8\uc774 \ud65c\ubc1c\ud788 \uac1c\ubc1c \uc911\uc774\uba70 \uc5c4\uaca9\ud55c HPAPI \uaca9\ub9ac \uc694\uac74\uc73c\ub85c \ub192\uc740 \ub9c8\uc9c4\uc744 \ucc3d\ucd9c\ud569\ub2c8\ub2e4. \uaddc\uc81c \uc57d\ubb3c\uc778 \uc911\ucd94\uc2e0\uacbd\uacc4(CNS) \uc57d\ubb3c\uc740 8.43%\uc758 CAGR\ub85c \ub354 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc73c\uba70, \ud2b9\uc218 \uae08\uace0 \ubc0f DEA \ud560\ub2f9\ub7c9 \uc900\uc218 \uc694\uac74\uc73c\ub85c \uc9c4\uc785 \uc7a5\ubcbd\uc774 \ub192\uc2b5\ub2c8\ub2e4. \uc2ec\ud608\uad00 \ubc0f \uac10\uc5fc\uc131 \uc9c8\ud658 API\ub294 \uac01\uac01 6.5-6.8% \uc131\uc7a5\uc744 \ubcf4\uc774\uba70, GLP-1 \uc791\uc6a9\uc81c\ub294 \ub300\uc0ac\uc131 \uc9c8\ud658 \uc218\uc694\ub97c 7% \uc774\uc0c1\uc73c\ub85c \ub04c\uc5b4\uc62c\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uace0\uac1d \uc720\ud615\ubcc4: \ubc14\uc774\uc624\ud14d\uc774 \ubb3c\ub7c9 \uc99d\uac00 \uc8fc\ub3c4<br \/>\n    *   \ubc14\uc774\uc624\ud14d \uae30\uc5c5\uc740 8.68%\uc758 CAGR\ub85c \ub9e4\ucd9c \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud558\uba70, CDMO \ud604\uae08 \ud750\ub984\uc744 \uc784\uc0c1 \uc9c4\ud589 \uc0c1\ud669\uacfc \uc5f0\uacc4\ud558\ub294 \ub9c8\uc77c\uc2a4\ud1a4 \uae30\ubc18 \uacc4\uc57d\uc744 \ucc44\ud0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uc18c\ud615 \uc81c\uc57d\uc0ac\ub294 2025\ub144 37.08%\ub85c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud588\uc73c\uba70, \ucd9c\uc2dc\ub97c \uc704\ud55c \uc790\ubcf8 \ubcf4\ud638\ub97c \uc704\ud574 \ud544\uc694\uc758 \ucd5c\ub300 85%\ub97c \uc544\uc6c3\uc18c\uc2f1\ud569\ub2c8\ub2e4. \ube45 \ud30c\ub9c8\ub294 6.2%\ub85c \uc644\ub9cc\ud558\uac8c \uc131\uc7a5\ud558\uc9c0\ub9cc, \uc7a5\uae30\uc801\uc778 \uc120\ud638 \uacf5\uae09\uc5c5\uccb4 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \ud1b5\ud574 \uc0dd\uc0b0 \ub2a5\ub825 \ud65c\uc6a9\ub3c4\ub97c \uc720\uc9c0\ud569\ub2c8\ub2e4. \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \uc5c5\uccb4\ub294 \uae30\ubcf8 \ubb3c\ub7c9\uc744 \ub298\ub9ac\uc9c0\ub9cc \uac00\uaca9\uc5d0 \ubbfc\uac10\ud558\uc5ec, \uaddc\uc81c \uc694\uac74\uc774 \uc5c6\ub294 \ud55c \uc778\ub3c4\ub098 \uc911\uad6d\uc73c\ub85c \uc8fc\ubb38\uc744 \ub3cc\ub9ac\ub294 \uacbd\uc6b0\uac00 \ub9ce\uc2b5\ub2c8\ub2e4.<\/p>\n<p>6. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc2dc\uc7a5 \uac00\uce58\uc758 39.63%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 5\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc2e0\uaddc \uc628\uc1fc\uc5b4\ub9c1 \ud504\ub85c\uc81d\ud2b8\uc640 BIOSECURE Act\ub85c \uc778\ud55c \uacf5\uae09 \uc7ac\ud3b8\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 6.4%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. ACG\uc758 \uc560\ud2c0\ub79c\ud0c0 \ucea1\uc290 \uacf5\uc7a5\uacfc Cambrex\uc758 \uc544\uc774\uc624\uc640 API \ud655\uc7a5 \ub4f1\uc774 \uad6d\ub0b4 \ubcf5\uc6d0\ub825 \uac15\ud654 \ucd94\uc138\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. FDA\uc758 \uac15\ud654\ub41c \uac10\uc2dc\ub294 2025\ub144 \uad6d\ub0b4\uc678 15\uac1c \uc2dc\uc124\uc5d0 \uacbd\uace0 \uc11c\ud55c\uc744 \ubc1c\ud589\ud558\uc5ec \uaddc\uc81c \uc900\uc218 \uae30\uc900\uacfc \ud55c\uacc4 \ube44\uc6a9\uc744 \ub192\uc600\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \ub3c5\uc77c, \uc2a4\uc704\uc2a4, \uc774\ud0c8\ub9ac\uc544\uac00 \uc0dd\uc0b0 \ub2a5\ub825\uc744 \uc9c0\ubc30\ud558\uba70, Lonza, Siegfried, Olon\uc740 2024-2025\ub144 \ub3d9\uc548 HPAPI \ubc0f \uc5f0\uc18d \ud750\ub984 \uc5c5\uadf8\ub808\uc774\ub4dc\uc5d0 \ucd1d 4\uc5b5 \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\uc2b5\ub2c8\ub2e4. \ube0c\ub809\uc2dc\ud2b8 \uad00\ub828 \uc774\uc911 \ub4f1\ub85d\uc740 \uc77c\ubd80 \ud504\ub85c\uc81d\ud2b8\ub97c \uc544\uc77c\ub79c\ub4dc\uc640 \ub124\ub35c\ub780\ub4dc\ub85c \uc774\ub3d9\uc2dc\ud0a4\uace0 \uc788\uc73c\uba70, \ub3d9\uc720\ub7fd\uc740 30-40%\uc758 \uc778\uac74\ube44 \uc808\uac10 \ud6a8\uacfc\ub97c \uc81c\uacf5\ud558\uc9c0\ub9cc \uc778\ub825 \ubd80\uc871\uc5d0 \uc9c1\uba74\ud574 \uc788\uc2b5\ub2c8\ub2e4. EMA\uc758 2025\ub144 \uc544\uc2dc\uc544 42\uac1c GMP \uac80\uc0ac\ub294 \ud488\uc9c8 \uac10\ub3c5\uc744 \uac15\ud654\ud558\uc5ec \uc2a4\ud3f0\uc11c\ub4e4\uc744 \uc9c0\uc5ed \uacf5\uae09\uc5c5\uccb4\ub85c \ub2e4\uc2dc \uc720\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 11.63%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc5d4\uc9c4\uc774\uba70, \uc778\ub3c4\uac00 \uc911\uad6d\uc758 \ub300\uc548\uc73c\ub85c \ubd80\uc0c1\ud558\uba74\uc11c \uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5\uc774 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. Syngene, Laurus Labs, Neuland\ub294 2024-2025\ub144 \ub3d9\uc548 3\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc0c8\ub85c\uc6b4 \ubbf8\uad6d \uacc4\uc57d\uc744 \uccb4\uacb0\ud588\uc73c\uba70, WuXi AppTec\uc758 \uc218\ucd9c \ubaa8\uba58\ud140\uc740 8.5% CAGR\ub85c \ub454\ud654\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uacfc \ud55c\uad6d\uc740 \uace0\ub9c8\uc9c4, \uae30\uc220 \uc911\uc2ec API \ub77c\uc778\uc5d0 \ud22c\uc790\ud558\uace0 \uc788\uc73c\uba70, \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\ub294 2027\ub144\uae4c\uc9c0 \uc18c\ubd84\uc790 \ubd84\uc57c\ub85c \ud655\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud638\uc8fc\ub294 R&#038;D \uc778\uc13c\ud2f0\ube0c\uc5d0 \ud798\uc785\uc5b4 \ucd08\uae30 \ub2e8\uacc4 \uc784\uc0c1 \uc5f0\uad6c\ub97c \uc720\uce58\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>7. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\ub85c \ubd84\uc0b0\ub418\uc5b4 \uc788\uc73c\uba70, Lonza, Catalent (\ud604\uc7ac Novo Holdings \uc18c\uc720), Patheon, WuXi STA, Siegfried\uac00 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 \uc0c1\ub2f9 \ubd80\ubd84\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4. Novo\uc758 2024\ub144 Catalent \uc778\uc218\ub294 GLP-1 \uc0dd\uc0b0 \ub2a5\ub825\uc744 \ud655\ubcf4\ud558\uace0 \ucd08\uacfc \ub300\uc5ed\ud3ed\uc744 \uc678\ubd80 \uacc4\uc57d\uc744 \ud1b5\ud574 \uc218\uc775\ud654\ud558\ub824\ub294 \uc6c0\uc9c1\uc784\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4. \uc120\ub450 \uae30\uc5c5\ub4e4\uc740 AI \uae30\ubc18 \uacf5\uc815 \ucd5c\uc801\ud654, \uc5f0\uc18d \ud750\ub984 \ud654\ud559 \ubc0f \uc2e4\uc2dc\uac04 \ubd84\uc11d\uc744 \ud1b5\ud574 \ud3d0\uae30\ubb3c\uc744 \uc904\uc774\uace0 \ub9c8\uc9c4\uc744 \ub192\uc774\ub294 \ubc29\uc2dd\uc73c\ub85c \ucc28\ubcc4\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Lonza\ub294 2024\ub144 \ud1b5\ud569 \ubc14\uc774\uc624 \uc758\uc57d\ud488, \ucca8\ub2e8 \ud569\uc131, \ud2b9\uc218 \ubaa8\ub2ec\ub9ac\ud2f0 \ubd80\ubb38\uc73c\ub85c \ubd84\ud560\ud558\uc5ec \uc0c1\ud488\ud654\ub41c \ucea1\uc290 \uc0ac\uc5c5\uc5d0\uc11c \ucca0\uc218\ud558\uace0 HPAPI \ubc0f \ubc14\uc774\uc624\ucee8\uc96c\uac8c\uc774\ud2b8 \ud2c8\uc0c8\uc2dc\uc7a5\uc5d0 \uc790\ubcf8\uc744 \uc9d1\uc911\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ud2b9\ud5c8 \ucd9c\uc6d0\uc740 \ud601\uc2e0 \uc5ed\ub7c9\uc744 \uac15\uc870\ud569\ub2c8\ub2e4. Lonza\uc640 Siegfried\ub294 2024-2025\ub144 \ub3d9\uc548 \ud750\ub984 \ubc0f \uce5c\ud658\uacbd \ud654\ud559 \ubc29\ubc95\uc5d0 \ub300\ud574 42\uac74\uc758 \ud2b9\ud5c8\ub97c \ucd9c\uc6d0\ud588\uc2b5\ub2c8\ub2e4. \uc18c\uaddc\ubaa8 \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc740 OEL \uc784\uacc4\uac12\uc774 0.1 \u00b5g\/m\u00b3 \ubbf8\ub9cc\uc778 \ucd08\uace0\uc5ed\uac00 API\uc640 18\uac1c\uc6d4 \uc774\ub0b4\uc5d0 \ubc30\ud3ec \uac00\ub2a5\ud55c \ubaa8\ub4c8\ud615 GMP \ubc15\uc2a4\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc744 \uac1c\ucc99\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \uc704\ubc18\uc740 \uc5ec\uc804\ud788 \uce58\uba85\uc801\uc778 \uc704\ud5d8\uc73c\ub85c \uc791\uc6a9\ud558\uba70, 2024\ub144 Gland Pharma \ubc0f \ub3d9\uc885 \uc5c5\uccb4\uc5d0 \ub300\ud55c FDA \uc81c\uc7ac\ub294 \uace0\uac1d\ub4e4\uc5d0\uac8c \ubd88\uc548\uac10\uc744 \uc8fc\uc5b4 \uc644\ubcbd\ud55c \ud488\uc9c8 \uc2dc\uc2a4\ud15c\uc758 \uc911\uc694\uc131\uc744 \ubd80\uac01\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \uace0\uac1d\ub4e4\uc774 \uaddc\ubaa8, \uaddc\uc81c \uc900\uc218 \ubc0f \uae30\uc220\uc801 \uc815\uad50\ud568\uc744 \uacb8\ube44\ud55c \ud30c\ud2b8\ub108\ub97c \uc6b0\uc120\uc2dc\ud568\uc5d0 \ub530\ub77c \ucd94\uac00\uc801\uc778 \ud1b5\ud569\uc774 \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>8. \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790<\/p>\n<p>*   Thermo Fisher Scientific, Inc.<br \/>\n*   Labcorp Drug Development<br \/>\n*   Cambrex Corporation<br \/>\n*   Catalent Inc.<br \/>\n*   Lonza Group AG<\/p>\n<p>9. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 3\uc6d4: Croda\ub294 \ucca8\ub2e8 \uc57d\ubb3c \uc804\ub2ec \uc2dc\uc2a4\ud15c\uc758 \uacf5\uae09 \ubcf4\uc548\uc744 \uac15\ud654\ud558\uae30 \uc704\ud574 \ud39c\uc2e4\ubca0\uc774\ub2c8\uc544\uc8fc \ub77c\ub9c8\ub974\uc5d0 23,680\ud3c9\ubc29\ud53c\ud2b8 \uaddc\ubaa8\uc758 \uc9c0\uc9c8 \uc81c\uc870 \uacf5\uc7a5\uc744 \uac1c\uc124\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: BioCina\uc640 NovaCina\ub294 \ud569\ubcd1\ud558\uc5ec \ud638\uc8fc\uc5d0 FDA \ubc0f EMA \uc2b9\uc778 \uc2dc\uc124\uc744 \uc6b4\uc601\ud558\ub294 \ubc14\uc774\uc624 \uc758\uc57d\ud488 \ubc0f \uc18c\ubd84\uc790 CDMO\ub97c \uc124\ub9bd\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc758\uc57d\ud488 \uac1c\ubc1c\ubd80\ud130 \uc81c\uc870\uae4c\uc9c0 \ud3ec\uad04\uc801\uc778 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\ub294 \uacc4\uc57d \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc870\uc9c1(CDMO) \uc911 \uc18c\ubd84\uc790 \ubd84\uc57c\uc5d0 \ucd08\uc810\uc744 \ub9de\ucdb0 \uc2dc\uc7a5 \ud604\ud669\uacfc \ubbf8\ub798 \uc804\ub9dd\uc744 \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc18c\ubd84\uc790 CDMO\ub294 \uc804\ubb38\uc801\uc778 \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\uba70, \uc81c\uc57d \uc0b0\uc5c5 \uac00\uce58 \uc0ac\uc2ac\uc5d0\uc11c \ud544\uc218\uc801\uc778 \uc5ed\ud560\uc744 \uc218\ud589\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd<br \/>\n\uc18c\ubd84\uc790 CDMO \uc2dc\uc7a5\uc740 2026\ub144 \uae30\uc900 2,071\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec(USD 207.16 billion) \uaddc\ubaa8\ub85c \ucd94\uc815\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 6.98%\uc758 \uacac\uc870\ud55c \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \u25b2\uc18c\ubd84\uc790 R&#038;D \ud30c\uc774\ud504\ub77c\uc778 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00 \u25b2\uc81c\uc57d\uc0ac\ub4e4\uc758 \ube44\uc6a9 \uc808\uac10 \ub178\ub825 \uac00\uc18d\ud654\uc5d0 \ub530\ub978 CDMO \ucc44\ud0dd \ud655\ub300 \u25b2\uace0\ud65c\uc131 \uc6d0\ub8cc\uc758\uc57d\ud488(HPAPI) \uc218\uc694 \uae09\uc99d \u25b2\ud2b9\ud5c8 \ub9cc\ub8cc \uc774\ud6c4 \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \uc0dd\uc0b0\ub7c9 \ud655\uc7a5 \u25b2AI \uae30\ubc18\uc758 \ub9c8\uc774\ud06c\ub85c \ubc30\uce58 API \uacf5\uc815 \uac15\ud654 \u25b2ESG(\ud658\uacbd, \uc0ac\ud68c, \uc9c0\ubc30\uad6c\uc870) \uacbd\uc601 \uae30\uc870\uc5d0 \ub530\ub978 \ud575\uc2ec API \uc0dd\uc0b0 \ub2a5\ub825\uc758 \uad6d\ub0b4 \ud68c\uadc0(Reshoring) \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<br \/>\n\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \u25b2\uc0dd\uc0b0 \ub2a5\ub825 \ubd80\uc871 \ubc0f CDMO \ub9ac\ub4dc \ud0c0\uc784 \uc7a5\uae30\ud654 \u25b2\uaddc\uc81c \ubbf8\uc900\uc218 \ubc0f FDA \uacbd\uace0 \uc11c\ud55c \ubc1c\uae09 \u25b2\uc911\uad6d\uc0b0 \ucca8\ub2e8 \uc911\uac04\uccb4\uc5d0 \ub300\ud55c \uacfc\ub3c4\ud55c \uc758\uc874\ub3c4 \u25b2\uc5d0\ub108\uc9c0 \uac00\uaca9 \ubcc0\ub3d9\uc131\uc73c\ub85c \uc778\ud55c \ub9c8\uc9c4 \uc555\ubc15 \ub4f1\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4.<\/p>\n<p>4. \uc8fc\uc694 \uc2dc\uc7a5 \ud2b8\ub80c\ub4dc \ubc0f \uc778\uc0ac\uc774\ud2b8<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc11c\ube44\uc2a4 \ubd80\ubb38: \uc81c\ud615 \ubc0f \ubd84\uc11d \uc11c\ube44\uc2a4 \ubd80\ubb38\uc740 \ud1b5\ud569 \uac1c\ubc1c \ubaa8\ub378\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 7.29%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5\ub960 \uc9c0\uc5ed: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc778\ub3c4\uac00 \uc911\uad6d\uc744 \ub300\uccb4\ud558\ub294 \uacf5\uae09\ucc98\ub85c \ubd80\uc0c1\ud558\uba74\uc11c \uc5f0\ud3c9\uade0 11.63%\ub85c \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc784\uc0c1 3\uc0c1 \uc81c\uc870 \uc2ac\ub86f \uc555\ubc15: \ud6c4\uae30 \ub2e8\uacc4 \ubc14\uc774\uc624\ud14d \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc99d\uac00\uc640 \uacfc\uac70 \ud22c\uc790 \ubd80\uc871\uc73c\ub85c \uc778\ud574 \uc784\uc0c1 3\uc0c1 \uc0dd\uc0b0 \ub2a5\ub825 \ud65c\uc6a9\ub960\uc774 85%\ub97c \ucd08\uacfc\ud558\uba70, \ub9ac\ub4dc \ud0c0\uc784\uc774 \ucd5c\ub300 24\uac1c\uc6d4\uae4c\uc9c0 \uae38\uc5b4\uc9c0\ub294 \uc555\ubc15\uc744 \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>5. \uc2dc\uc7a5 \uc138\ubd84\ud654<br \/>\n\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc744 \ub2e4\uc74c\uacfc \uac19\uc740 \uae30\uc900\uc73c\ub85c \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<br \/>\n*   \uc11c\ube44\uc2a4 \uc720\ud615: API \uac1c\ubc1c, API \uc81c\uc870, \uc644\uc81c \uc758\uc57d\ud488 \uac1c\ubc1c, \uc644\uc81c \uc758\uc57d\ud488 \uc81c\uc870, \uc81c\ud615 \ubc0f \ubd84\uc11d \uc11c\ube44\uc2a4.<br \/>\n*   \uc6b4\uc601 \uaddc\ubaa8: \uc804\uc784\uc0c1, \uc784\uc0c1 1\uc0c1, \uc784\uc0c1 2\uc0c1, \uc784\uc0c1 3\uc0c1, \uc0c1\uc5c5\ud654 \ub2e8\uacc4.<br \/>\n*   \uce58\ub8cc \ubd84\uc57c: \uc885\uc591\ud559, \uc2ec\ud608\uad00 \uc9c8\ud658, \uac10\uc5fc\uc131 \uc9c8\ud658, \uc911\ucd94\uc2e0\uacbd\uacc4 \uc9c8\ud658, \ub300\uc0ac \uc7a5\uc560 \ubc0f \uae30\ud0c0.<br \/>\n*   \uace0\uac1d \uc720\ud615: \ub300\ud615 \uc81c\uc57d\uc0ac, \uc911\uc18c\ud615 \uc81c\uc57d\uc0ac, \ubc14\uc774\uc624\ud14d \uae30\uc5c5, \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \ud68c\uc0ac.<br \/>\n*   \uc9c0\uc5ed: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ub4f1), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d \ub4f1), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<br \/>\n\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Ajinomoto Bio-Pharma Services, Catalent Inc., Lonza Group AG, Thermo Fisher Scientific, Inc., WuXi STA \ub4f1 \uc8fc\uc694 20\uac1c \uae30\uc5c5\uc5d0 \ub300\ud55c \uc0c1\uc138 \ud504\ub85c\ud544(\uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ud3ec\ud568)\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<br \/>\n\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5\uc758 \ubbf8\uac1c\ucc99 \uc601\uc5ed(White-space)\uacfc \ubbf8\ucda9\uc871 \uc218\uc694\ub97c \ud3c9\uac00\ud558\uc5ec \ud5a5\ud6c4 \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-53349","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/53349"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=53349"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/53349\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=53349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=53349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=53349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}